Drug-induced chronic hepatic disease.
A number of chronic hepatic lesions can result from adverse reactions to medicinal agents. Such lesions include a form of chronic active hepatitis; hepatic steatosis, phoepholipidosis and granulomatosis; several vascular lesions; two types of noncirrhotic portal hypertension; several types of cirrhosis and several neoplasms.
D006528:Carcinoma, Hepatocellular / Q000139:chemically induced; D056486:Chemical and Drug Induced Liver Injury / Q000473:pathology; D002908:Chronic Disease; D005234:Fatty Liver / Q000139:chemically induced; D006390:Hemangioendothelioma / Q000139:chemically induced; D006589:Hexestrol / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D006975:Hypertension, Portal / Q000139:chemically induced; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000139:chemically induced; D008113:Liver Neoplasms / Q000139:chemically induced; D008727:Methotrexate / Q000009:adverse effects; D009336:Necrosis; D010114:Oxyphenisatin Acetate / Q000009:adverse effects
D006589:Hexestrol; D010114:Oxyphenisatin Acetate; D008727:Methotrexate